1
/
of
1
ELK Biotechnology
SKU:ELK8570
Human PIVKA-II(Protein Induced Vitamin K Absence or Antagonist-II) ELISA Kit
Human PIVKA-II(Protein Induced Vitamin K Absence or Antagonist-II) ELISA Kit
Regular price
$376.00 USD
Regular price
Sale price
$376.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Human PIVKA-II(Protein Induced Vitamin K Absence or Antagonist-II) ELISA Kit
Overview
| Product name: | Human PIVKA-II(Protein Induced Vitamin K Absence or Antagonist-II) ELISA Kit |
| Reactivity: | Human |
| Alternative Names: | PIVKA-II; PIVKA II |
| Assay Type: | Sandwich |
| Sensitivity: | 0.125 ng/mL |
| Standard: | 20 ng/mL |
| Range: | 0.32-20 ng/mL |
| Sample Type: | serum, plasma and other biological fluids |
| Assay Length: | 3.5h |
| Research Area: | Hematology |
| Test principle: | The test principle applied in this kit is Sandwich enzyme immunoassay. The microtiter plate provided in this kit has been pre-coated with an antibody specific to Human PIVKA-II. Standards or samples are added to the appropriate microtiter plate wells then with a biotin-conjugated antibody specific to Human PIVKA-II. Next, Avidin conjugated to Horseradish Peroxidase (HRP) is added to each microplate well and incubated. After TMB substrate solution is added, only those wells that contain Human PIVKA-II, biotin-conjugated antibody and enzyme-conjugated Avidin will exhibit a change in color. The enzyme-substrate reaction is terminated by the addition of sulphuric acid solution and the color change is measured spectrophotometrically at a wavelength of 450nm ± 10nm. The concentration of Human PIVKA-II in the samples is then determined by comparing the OD of the samples to the standard curve. |
Standard curve
| Concentration (ng/mL) | OD | Corrected OD |
|---|---|---|
| 20.00 | 2.218 | 2.135 |
| 10.00 | 1.677 | 1.594 |
| 5.00 | 1.235 | 1.152 |
| 2.50 | 0.969 | 0.886 |
| 1.25 | 0.525 | 0.442 |
| 0.63 | 0.426 | 0.343 |
| 0.32 | 0.174 | 0.091 |
| 0.00 | 0.083 | 0.000 |

Precision
Intra-assay Precision (Precision within an assay):CV%<8%
Three samples of known concentration were tested twenty times on one plate to assess intra-assay precision.
Inter-assay Precision (Precision between assays):CV%<10%
Three samples of known concentration were tested in forty separate assays to assess inter-assay precision.
Recovery
Matrices listed below were spiked with certain level of recombinant PIVKA-II and the recovery rates were calculated by comparing the measured value to the expected amount of PIVKA-II in samples.
| Matrix | Recovery range | Average |
|---|---|---|
| serum(n=5) | 78-90% | 84% |
| EDTA plasma(n=5) | 90-105% | 97% |
| Heparin plasma(n=5) | 95-107% | 101% |
Linearity
The linearity of the kit was assayed by testing samples spiked with appropriate concentration of PIVKA-II and their serial dilutions. The results were demonstrated by the percentage of calculated concentration to the expected.
| Matrix | 1:2 | 1:4 | 1:8 | 1:16 |
|---|---|---|---|---|
| serum(n=5) | 86-97% | 83-96% | 91-103% | 96-105% |
| EDTA plasma(n=5) | 85-94% | 87-99% | 85-101% | 79-90% |
| Heparin plasma(n=5) | 86-95% | 93-103% | 87-98% | 85-96% |
Share
